The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Kim Austin D. since 2019.
This trader's CIK number is 1746240.
At the time of last reporting, Kim Austin D. was the EVP,General Counsel, Secretary of Acadia Pharmaceuticals Inc. (stock ticker symbol ACAD).
Also see all insider trading activities at Acadia Pharmaceuticals Inc.
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2024 | ACAD | 0 | $0 | 590 | $17,676 | 1,634 | $0 |
| 2023 | ACAD | 0 | $0 | 20,134 | $430,494 | 47,799 | $0 |
| 2022 | ACAD | 0 | $0 | 1,468 | $29,484 | 4,638 | $0 |
| 2021 | ACAD | 0 | $0 | 3,839 | $164,226 | 4,638 | $0 |
| 2020 | ACAD | 0 | $0 | 9,822 | $447,396 | 11,754 | $153,824 |
| 2019 | ACAD | 0 | $0 | 17,500 | $788,585 | 17,500 | $307,649 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2024-01-06 | ACAD | Option Ex | 1,634 | .00 | 0 |
| 2024-01-08 | ACAD | Sale | 590 | 29.96 | 17,676 |
| 2023-10-05 | ACAD | Option Ex | 36,174 | .00 | 0 |
| 2023-10-06 | ACAD | Sale | 16,369 | 21.96 | 359,463 |
| 2023-04-29 | ACAD | Option Ex | 3,005 | .00 | 0 |
| 2023-05-01 | ACAD | Sale | 917 | 21.18 | 19,422 |
| 2023-04-06 | ACAD | Sale | 1,456 | 18.16 | 26,440 |
| 2023-04-05 | ACAD | Option Ex | 4,773 | .00 | 0 |
| 2023-02-23 | ACAD | Option Ex | 2,214 | .00 | 0 |
| 2023-02-24 | ACAD | Sale | 803 | 18.78 | 15,080 |
| 2023-01-06 | ACAD | Option Ex | 1,633 | .00 | 0 |
| 2023-01-09 | ACAD | Sale | 589 | 17.13 | 10,089 |
| 2022-04-29 | ACAD | Option Ex | 3,005 | .00 | 0 |
| 2022-05-02 | ACAD | Sale | 894 | 18.18 | 16,254 |
| 2022-01-06 | ACAD | Option Ex | 1,633 | .00 | 0 |
| 2022-01-06 | ACAD | Sale | 574 | 23.05 | 13,230 |
| 2021-04-29 | ACAD | Option Ex | 3,005 | .00 | 0 |
| 2021-04-30 | ACAD | Sale | 1,054 | 20.33 | 21,427 |
| 2021-02-04 | ACAD | Sale | 2,107 | 50.61 | 106,635 |
| 2021-01-06 | ACAD | Option Ex | 1,633 | .00 | 0 |
| 2021-01-06 | ACAD | Sale | 678 | 53.34 | 36,164 |
| 2020-10-27 | ACAD | Option Ex | 8,750 | 17.58 | 153,824 |
| 2020-10-27 | ACAD | Sale | 8,750 | 45.10 | 394,633 |
| 2020-04-30 | ACAD | Sale | 1,072 | 49.22 | 52,763 |
| 2020-04-29 | ACAD | Option Ex | 3,004 | .00 | 0 |
| 2019-12-11 | ACAD | Sale | 17,500 | 45.06 | 788,585 |
| 2019-12-11 | ACAD | Option Ex | 17,500 | 17.58 | 307,649 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Kim Austin D. (EVP,General Counsel, Secretary of Acadia Pharmaceuticals Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.